Due to the ongoing shortage of BCG, gemcitabine has been increasingly used for first-line NMIBC therapy. N-803’s ability to activate natural killer and CD8+ T cells, thus the innate immune system, to ...

I recommend that all patients with high-risk disease undergo pathologic confirmation of response, with cystoscopy, barbotage cytology, and biopsies of the previous tumor sites and areas of CIS ...